top of page
LATEST NEWS
Dr. Mark A. Exley shares what excites him most about joining LIfT as Chief Scientific Officer and the potential of LIfT’s technology
In this video, Dr. Mark A. Exley shares his background in biotech, what makes our neutrophil-based approach to cancer therapy so...
Apr 8
LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer
Mark brings 30 years of experience in R&D spanning discovery to late-stage clinical development London, 7 April 2025 – LIfT BioSciences,...
Apr 7
Dr Michael McCarthy discusses one of the biggest challenges in solid tumour treatment: treatment resistance
We spoke to Dr Michael McCarthy, Consultant Medical Oncologist at University Hospital Galway, regarding what treatment resistance in...
Apr 3
bottom of page